Company intelligence / Profile preview

Zensorium

Ownership: Private
Development stage: Commercial

Overview

Zensorium develops innovative healthcare solutions including digital health devices that enable discovery of new biomarkers and personalized insights. Their products include the ACT kidney analysis device for point-of-care screening without refrigeration, and the Being smartwatch for mood and activity tracking. Clinical results are not applicable as these are medical devices rather than therapeutics.

Therapeutic areas: OtherNephrology
Modalities: DeviceDigital health solution
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Zensorium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zensorium.

Explore the full profile